Association of Defective Regulation of Autoreactive Interleukin-6-Producing Transitional B Lymphocytes With Disease in Patients With Systemic Sclerosis
出版年份 2018 全文链接
标题
Association of Defective Regulation of Autoreactive Interleukin-6-Producing Transitional B Lymphocytes With Disease in Patients With Systemic Sclerosis
作者
关键词
-
出版物
Arthritis & Rheumatology
Volume 70, Issue 3, Pages 450-461
出版商
Wiley
发表日期
2017-11-30
DOI
10.1002/art.40390
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In-depth characterization of CD24 high CD38 high transitional human B cells reveals different regulatory profiles
- (2016) Quentin Simon et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- NFκB1 is essential to prevent the development of multiorgan autoimmunity by limiting IL-6 production in follicular B cells
- (2016) Elisha de Valle et al. JOURNAL OF EXPERIMENTAL MEDICINE
- BSR and BHPR guideline for the treatment of systemic sclerosis
- (2016) Christopher P. Denton et al. RHEUMATOLOGY
- Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
- (2014) Suzana Jordan et al. ANNALS OF THE RHEUMATIC DISEASES
- 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
- (2013) Frank van den Hoogen et al. ARTHRITIS AND RHEUMATISM
- Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway
- (2012) Saba Alzabin et al. ANNALS OF THE RHEUMATIC DISEASES
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
- (2011) Markus F. Neurath et al. CYTOKINE & GROWTH FACTOR REVIEWS
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
- (2010) Dimitrios Daoussis et al. RHEUMATOLOGY INTERNATIONAL
- B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis
- (2009) Robert Lafyatis et al. ARTHRITIS AND RHEUMATISM
- Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells
- (2009) S. Suryani et al. BLOOD
- Killer B lymphocytes: the evidence and the potential
- (2009) Steven K. Lundy INFLAMMATION RESEARCH
- The Development and Function of Regulatory B Cells Expressing IL-10 (B10 Cells) Requires Antigen Receptor Diversity and TLR Signals
- (2009) K. Yanaba et al. JOURNAL OF IMMUNOLOGY
- Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
- (2009) Dimitrios Daoussis et al. RHEUMATOLOGY
- CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced Scleroderma
- (2008) Ayumi Yoshizaki et al. AMERICAN JOURNAL OF PATHOLOGY
- Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study
- (2008) V Smith et al. ANNALS OF THE RHEUMATIC DISEASES
- Sites and Stages of Autoreactive B Cell Activation and Regulation
- (2008) Mark J. Shlomchik IMMUNITY
- IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis
- (2008) Satoshi Serada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search